← 產業報告目錄
RNA Editing Market Size, Share & Trends Analysis Report By Type of RNA (Messenger RNA Modifications, Transfer RNA Modification, Ribosomal RNA Modification), By Application (Cancer, Genetic Disorders, Temporary Maladies), By Technique (Insertion/Deletion, Deamination), By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-24頁數 165報告編號 INSIGHTACE-12c122e58b
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2023, the RNA Editing Market worldwide was assessed at USD 15.2 billion. Analysts project it will increase to USD 23.1 billion by 2031, at a CAGR of 5.60% spanning 2024 to 2031.
At its core, RNA Editing pertains to landscape are mountingly turning to these solutions to meet contemporary demands.
The market's upward path is fueled by mounting healthcare spending, technological evolution, and the mounting focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region forecasted to deliver the strongest growth trajectory through the forecast period, fueled by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global RNA Editing Market Snapshot
Chapter 4. Global RNA Editing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global RNA Editing Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on RNA Editing Industry Trends
Chapter 5. RNA Editing Market Segmentation 1: By Type of RNA, Estimates & Trend Analysis
5.1. Market Share by Type of RNA, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of RNA:
5.2.1. Messenger RNA Modification
5.2.2. Transfer RNA Modification
5.2.3. Ribosomal RNA Modification
Chapter 6. RNA Editing Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Applications:
6.2.1. Cancer
6.2.2. Genetic Disorders
6.2.3. Temporary Maladie
Chapter 7. RNA Editing Market Segmentation 3: By Technique, Estimates & Trend Analysis
7.1. Market Share by Technique, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Techniques:
7.2.1. Insertion/ Deletion
7.2.2. Deamination
Chapter 8. RNA Editing Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global RNA Editing Market, Regional Snapshot 2023 & 2031
8.2. North America
8.2.1. North America RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of RNA, 2024-2031
8.2.3. North America RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.2.4. North America RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2024-2031
8.3. Europe
8.3.1. Europe RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of RNA, 2024-2031
8.3.3. Europe RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.3.4. Europe RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2024-2031
8.4. Asia Pacific
8.4.1. Asia Pacific RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of RNA, 2024-2031
8.4.3. Asia Pacific RNA Editing Market Revenue (US$ Million) Estimates and Forecasts By Application, 2024-2031
8.4.4. Asia Pacific RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2024-2031
8.5. Latin America
8.5.1. Latin America RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of RNA, 2024-2031
8.5.3. Latin America RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.5.4. Latin America RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2024-2031
8.6. Middle East & Africa
8.6.1. Middle East & Africa RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of RNA, 2024-2031
8.6.3. Middle East & Africa RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.6.4. Middle East & Africa RNA Editing Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. ProQR Therapeutics NV
9.2.1.1. Business Overview
9.2.1.2. Key Product/Service Offerings
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Sirna Therapeutics, Inc.
9.2.3. Shape Therapeutics, Inc.
9.2.4. Korro Bio, Inc.
9.2.5. Beam Therapeutics, Inc.
9.2.6. QIAGEN N.V.
9.2.7. UniQure NV (UniQure)
9.2.8. LAVA Therapeutics N.V.
9.2.9. argenx SE
9.2.10. Arrowhead Pharmaceuticals, Inc.
9.2.11. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們